Cato Research Appoints Life Sciences Leader And Innovator To Executive Chairman

Dr. Mark Goldberg Joins Board to Support Company’s Growth and Expansion
DURHAM, NC – April 3, 2019 – Cato Research, LLC (CATO), a global provider of
regulatory and clinical research services, announced today that its board of directors
has appointed Mark Goldberg, M.D. to executive chairman, effective immediately. Dr.
Goldberg brings to CATO more than 25 years of leadership and innovation experience
in building premier life sciences businesses. Read Full Press Release